406 related articles for article (PubMed ID: 8439955)
1. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
[TBL] [Abstract][Full Text] [Related]
3. IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.
Ferrantini M; Giovarelli M; Modesti A; Musiani P; Modica A; Venditti M; Peretti E; Lollini PL; Nanni P; Forni G
J Immunol; 1994 Nov; 153(10):4604-15. PubMed ID: 7963533
[TBL] [Abstract][Full Text] [Related]
4. Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir.
Santodonato L; Ferrantini M; Gabriele L; Proietti E; Venditti M; Musiani P; Modesti A; Modica A; Lupton SD; Belardelli F
Hum Gene Ther; 1996 Jan; 7(1):1-10. PubMed ID: 8825863
[TBL] [Abstract][Full Text] [Related]
5. Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.
Gabriele L; Kaido T; Woodrow D; Moss J; Ferrantini M; Proletti E; Santodonato L; Rozera C; Maury C; Belardelli F
Am J Pathol; 1995 Aug; 147(2):445-60. PubMed ID: 7639337
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.
Yasui H; Proietti E; Vignaux F; Eid P; Gresser I
Cancer Res; 1990 Jun; 50(12):3533-9. PubMed ID: 2140290
[TBL] [Abstract][Full Text] [Related]
7. Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines.
Santodonato L; D'Agostino G; Santini SM; Carlei D; Musiani P; Modesti A; Signorelli P; Belardelli F; Ferrantini M
Gene Ther; 1997 Nov; 4(11):1246-55. PubMed ID: 9425449
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Friend leukemia cell visceral metastases by a new monoclonal antibody and role of the immune system of the host in its action.
Sala A; Gresser I; Chassoux D; Maury C; Santodonato L; Eid P; Maunoury MT; Barca S; Cianfriglia M; Belardelli F
Cancer Res; 1992 May; 52(10):2880-9. PubMed ID: 1581903
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models.
Tüting T; Gambotto A; Baar J; Davis ID; Storkus WJ; Zavodny PJ; Narula S; Tahara H; Robbins PD; Lotze MT
Gene Ther; 1997 Oct; 4(10):1053-60. PubMed ID: 9415311
[TBL] [Abstract][Full Text] [Related]
10. Murine interferon-alpha1 gene-transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to interferon-alpha/beta therapy.
Rozera C; Mecchia M; Gresser I; Bandu MT; Proietti E; Venditti M; Sestili P; Santini SM; Fais S; Belardelli F; Ferrantini M
Cancer Gene Ther; 1999; 6(3):246-53. PubMed ID: 10359210
[TBL] [Abstract][Full Text] [Related]
11. 31P-nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.
Proietti E; Carpinelli G; Di Vito M; Belardelli F; Gresser I; Podo F
Cancer Res; 1986 Jun; 46(6):2849-57. PubMed ID: 2421886
[TBL] [Abstract][Full Text] [Related]
12. Antitumor potential of interferon-gamma: retroviral expression of mouse interferon-gamma cDNA in two kinds of highly metastatic mouse tumor lines reduces their tumorigenicity.
Yanagihara K; Seyama T; Watanabe Y
Nat Immun; 1994; 13(2-3):102-12. PubMed ID: 8173232
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models.
Hiroishi K; Tüting T; Tahara H; Lotze MT
Gene Ther; 1999 Dec; 6(12):1988-94. PubMed ID: 10637450
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
[TBL] [Abstract][Full Text] [Related]
15. Acute rejection of interferon-treated leukemia cells injected into lethally irradiated syngeneic mice.
Neri M; Zei T; Tentori L; Bonmassar E; Affabris E; Iorio AM
Nat Immun; 1993; 12(6):302-15. PubMed ID: 7505668
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
[TBL] [Abstract][Full Text] [Related]
17. Growth properties, differentiation capacity and oncogene expression in metastatic and nonmetastatic Friend leukemia cell variants.
Sala A; Benedetto A; Elia G; Pulciani S; Ciotta C; Parlanti E; Santodonato L; Belardelli F
Invasion Metastasis; 1991; 11(4):192-203. PubMed ID: 1765432
[TBL] [Abstract][Full Text] [Related]
18. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
19. Effect of in vitro interferon treatment on the rapid clearance of murine leukemia cells in vivo.
Neri M; Zei T; Rossi GB; Coccia EM; Bonmassar E; Iorio AM
J Biol Regul Homeost Agents; 1990; 4(2):60-6. PubMed ID: 1701956
[TBL] [Abstract][Full Text] [Related]
20. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.
Dong Z; Greene G; Pettaway C; Dinney CP; Eue I; Lu W; Bucana CD; Balbay MD; Bielenberg D; Fidler IJ
Cancer Res; 1999 Feb; 59(4):872-9. PubMed ID: 10029078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]